SARISSA CAPITAL MANAGEMENT LP

PrivateCIK: 1577524
Location

GREENWICH, CT

πŸ“‹ What this filing means

SARISSA CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $154.39M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

7
Positions
$154.39M
Total AUM (reported)
21.47M
Total Shares

Allocation by class

TOTAL AUM$154.39M7 positions
COM$103.38M67.0%
SPONSORED ADR$20.15M13.1%
COM NEW$19.44M12.6%
COM CL A$11.42M7.4%

Portfolio Concentration

Top 374.4%4–1025.6%TOP 10100.0%0%100%
Top 3$114.83M74.4%
4–10$39.56M25.6%

Top 3 weight

74.4%

Top 10 weight

100.0%

Voting Authority Distribution

Total shares with voting rights: 21.47M

Sole

Full voting authority

21.47M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole7
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings7
Rows:

INNOVIVA INC

SOLE
COM
Shares2.82M
TypeSH
Market value$56.57M
36.64%
Sole
2.82M
Shared
0.00
None
0.00

NEUROCRINE BIOSCIENCES INC

SOLE
COM
Shares303.15K
TypeSH
Market value$38.10M
24.68%
Sole
303.15K
Shared
0.00
None
0.00

AMARIN CORP PLC

SOLE
SPONSORED ADR
Shares1.24M
TypeSH
Market value$20.15M
13.05%
Sole
1.24M
Shared
0.00
None
0.00

CYTOKINETICS INC

SOLE
COM NEW
Shares588.36K
TypeSH
Market value$19.44M
12.59%
Sole
588.36K
Shared
0.00
None
0.00

IRONWOOD PHARMACEUTICALS INC

SOLE
COM CL A
Shares15.92M
TypeSH
Market value$11.42M
7.40%
Sole
15.92M
Shared
0.00
None
0.00

LANTHEUS HLDGS INC

SOLE
COM
Shares96.25K
TypeSH
Market value$7.88M
5.10%
Sole
96.25K
Shared
0.00
None
0.00

VOR BIOPHARMA INC

SOLE
COM
Shares508.02K
TypeSH
Market value$823.0K
0.53%
Sole
508.02K
Shared
0.00
None
0.00
SARISSA CAPITAL MANAGEMENT LP 13F Holdings β€” 7 Positions | Finecho